PIK3CA-related overgrowth spectrum: animal model and drug discovery

被引：5
|
作者：
Venot, Quitterie [1 ,2 ]
Canaud, Guillaume [1 ,2 ,3 ,4 ]
机构：
[1] Inst Necker Enfants Malad, INSERM, U1151, Paris, France
[2] Univ Paris, Paris, France
[3] Hop Necker Enfants Malad, AP HP, Unite Hypercroissance Dysharmonieuse, Paris, France
[4] Hop Necker Enfants Malad, AP HR, Serv Nephrol Transplantat Adultes, Paris, France
来源：
COMPTES RENDUS BIOLOGIES | 2021年 / 344卷 / 02期
关键词：
PIK3CA; Animal model; Clinical trial; PIK3CA-related overgrowth spectrum; Mosaicism; PIK3CA(H1047R) MUTATION; DIAGNOSIS; PIK3CA; EXPRESSION;
D O I：
10.5802/crbiol.50
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
This review recapitulates the recent knowledge accumulation on overgrowth syndrome related to gain of function of the phosphoinositide3 kinase (PI3K)-alpha. These disorders, known as PIK3CA related overgrowth syndromes (PROS) are caused by somatic PIK3CA mutation occurring during embryogenesis. We summarize here the currently available animal models and new treatments undergoing development.
引用
收藏
页码：189 / 201
页数：13
相关论文
共 50 条
  • [31] PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer
    Loi, Sherene
    Michiels, Stefan
    Baselga, Jose
    Bartlett, John M. S.
    Singhal, Sandeep K.
    Sabine, Vicky S.
    Sims, Andrew H.
    Sahmoud, Tarek
    Dixon, J. Michael
    Piccart, Martine J.
    Sotiriou, Christos
    PLOS ONE, 2013, 8 (01):
  • [32] Early diagnosis enabling precision medicine treatment in a young boy with PIK3R1-related overgrowth
    Schonewolf-Greulich, Bitten
    Karstensen, Helena Gasdal
    Hjortshoj, Tina D.
    Jorgensen, Finn Stener
    Harder, Katja M.
    Frevert, Susanne
    Hove, Hanne
    Diness, Birgitte R.
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2022, 65 (10)
  • [33] Syndromic vascular malformations related to the PIK3CA and RAS pathways: A clinical and imaging review
    Tsujioka, Yuko
    Nozaki, Taiki
    Niimi, Yasunari
    Starkey, Jay
    Hasegawa, Daisuke
    Kondo, Mutsuko
    Enokizono, Mikako
    Makidono, Akari
    Kono, Tatsuo
    Jinzaki, Masahiro
    CLINICAL IMAGING, 2022, 89 : 162 - 173
  • [34] Zebrafish: An emerging model system to study liver diseases and related drug discovery
    Katoch, Swati
    Patial, Vikram
    JOURNAL OF APPLIED TOXICOLOGY, 2021, 41 (01) : 33 - 51
  • [35] Tumor-intrinsic PIK3CA represses tumor immunogenicity in a model of pancreatic cancer
    Sivaram, Nithya
    McLaughlin, Patrick A.
    Han, Han V.
    Petrenko, Oleksi
    Jiang, Ya-Ping
    Ballou, Lisa M.
    Pham, Kien
    Liu, Chen
    van der Velden, Adrianus W. M.
    Lin, Richard Z.
    JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (08) : 3264 - 3276
  • [36] Phenotypic and genetic spectrum of isolated macrodactyly: somatic mosaicism of PIK3CA and AKT1 oncogenic variants
    Tian, Wen
    Huang, Yingzhao
    Sun, Liying
    Guo, Yang
    Zhao, Sen
    Lin, Mao
    Dong, Xiying
    Zhong, Wenyao
    Yin, Yuehan
    Chen, Zefu
    Zhang, Nan
    Zhang, Yuanqiang
    Wang, Lianlei
    Lin, Jiachen
    Yan, Zihui
    Yang, Xinzhuang
    Zhao, Junhui
    Qiu, Guixing
    Zhang, Jianguo
    Wu, Zhihong
    Wu, Nan
    ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (01)
  • [37] PIK3CA mutation spectrum in urothelial carcinoma reflects cell context-dependent signaling and phenotypic outputs
    Ross, R. L.
    Askham, J. M.
    Knowles, M. A.
    ONCOGENE, 2013, 32 (06) : 768 - 776
  • [38] Sensitivities and Dependencies of BRAF Mutant Colorectal Cancer Cell Lines with or without PIK3CA Mutations for Discovery of Vulnerabilities with Therapeutic Potential
    Voutsadakis, Ioannis A.
    MEDICINA-LITHUANIA, 2022, 58 (10):
  • [39] A PIK3CA transgenic mouse model with chemical carcinogen exposure mimics human oral tongue tumorigenesis
    Tan, Melody T.
    Wu, Jean G.
    Callejas-Valera, Juan Luis
    Schwarz, Richard A.
    Gillenwater, Ann M.
    Richards-Kortum, Rebecca R.
    Vigneswaran, Nadarajah
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2020, 101 (1-2) : 45 - 54
  • [40] Evaluation of PIK3CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer
    Domingo, Enric
    Church, David N.
    Sieber, Oliver
    Ramamoorthy, Rajarajan
    Yanagisawa, Yoko
    Johnstone, Elaine
    Davidson, Brian
    Kerr, David J.
    Tomlinson, Ian P. M.
    Midgley, Rachel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (34) : 4297 - U34
12345